Curative-Intention Surgery with Lobe-Specific Versus Systematic Lymph Node Dissection in Clinical Stage IA–IB Non-Small Cell Lung Cancer: Our Experience and Literature Review
For clinical stage IA-IB NSCLC, LS-LND offers oncologic outcomes that are comparable to S-LND, with a potential for reduced postoperative complications. The findings from our institution align with these trends observed in the literature. While these results suggest potential advantages of lobe-specific approaches, definitive conclusions require further validation through larger, prospective randomized studies to confirm the clinical benefits of LS-LND in early-stage NSCLC.
Authors
- Mihnea Davidescu (ORCID: https://orcid.org/0000-0002-0841-1352)
- Teodor Horvat
- Felix Bratosin (ORCID: https://orcid.org/0000-0003-4711-4315)
- Bogdan Tanase (ORCID: https://orcid.org/0000-0002-9286-9023)
- Gabriel Veniamin Cozma (ORCID: https://orcid.org/0000-0002-1646-9319)
- Călin Muntean (ORCID: https://orcid.org/0000-0002-0497-0405)
- Sorina Maria Denisa Laitin (ORCID: https://orcid.org/0009-0001-5436-5158)
- Alin Burlacu (ORCID: https://orcid.org/0000-0001-9330-4107)
- Claudiu Nistor (ORCID: https://orcid.org/0000-0002-2274-5666)
- Alin Nicola
Institutions
- Carol Davila University of Medicine and Pharmacy (RO)
- Victor Babeș University of Medicine and Pharmacy Timișoara (RO)
- Institutul Oncologic Bucuresti (RO)
Publication Details
- Journal
- Healthcare
- Published
- 2025-04-21
- DOI
- https://doi.org/10.3390/healthcare13080957
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00